
Bridging science and care: Advancing biomedical innovation
As public funding becomes more uncertain, lab and clinical services professionals are increasingly being called on to help.

Bayer extends CEO contract amid 'signs of success'
Bayer's chief executive Bill Anderson looks set to keep his role until nearly the decade, as his turnaround plan starts to deliver results.


UK plan to lead life sciences gets mixed response
The UK has unveiled its plan to revitalise the life sciences sector and become a global leader by 2030, but a pharma trade group says it falls short.

From pilots to impact: What it really takes to scale GenAI i...
It’s no longer about what GenAI can do. It’s about what it should do – and whether it can consistently deliver value at scale.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content

The Inaugural Market Access for CNS Therapeutics Summit Has ...
The only dedicated forum focused on tackling the unique commercial and reimbursement challenges facing treatments for neurodegeneration...

5th Oligonucleotides for CNS Summit
The Oligonucleotides for CNS Summit returns for its 5th year to address key challenges in durability, scalability, potency and CNS tropism

Immune Cell Engager Partnering & Investment Summit
Driving high ROI across immune cell engagers through strategic partnerships & investments, capitalizing on novel targets & asset tunability...

2nd ADC & Novel Conjugates Partnering & Investment Summit
Refine your strategy, sharpen your positioning, and meet the right partners - all at the most efficient networking event of the ADCconference calendar

2nd Autoimmunity & Inflammation Partnering & Investment Summ...
Driving deal-making across targeted cell depletion, checkpoint agonism, tolerance, and oral anti-inflammatory biologics...